Motivation: At present time, there are many different data sets obtained as the results of
different transcription starts, influence of different nucleotide motifs on translation efficacy in human and mouse we looked through and selected a range of datasets on common cell lines. Selected datasets will be stored with the results of our calculations on translation efficacy performed during the project using a BioUML platform.
Results: For storage and analysis of the selected from different sources datasets, a RiboSeqDB database was created. Currently, our database comprising 290 data samples of 21 datasets for human and mouse is being further developed acquiring new features and possibilities for users in navigation, data processing and analysis. Integration of the selected data sets and the results of calculations supported with mathematical tools/instruments, user and API interface of BioUML make RiboSeqDB an important part of original, extensible platform for research in the frames of 'Virtual human' conception.
Availability: Demo access at http://micro.biouml.org/bioumlweb/, tab 'Databases'.
Background
A RiboSeqDB repository has been developed in the frames of our analysis of transcription and translation efficacy in mouse and human cells. This work is a branch of our activity in progression of the 'Virtual Human' modeling, and the obtained results will become an important part of it. For this purpose, the databases Sequence Read Archive (SRA) [1] and Gene Expression Omnibus (GEO) [2] were scanned and the appropriate data sets satisfying several conditions were chosen: taxon (human or mouse), data type (mRNA-seq or ribosome footprint) and availability of description of experiment -and included in our repository. All available data sets for human and mouse were found, summarized and those utility for further analysis was estimated for every data set. RiboSeqDB does not contain raw or processed data downloaded from SRA and GEO, but contains structured summary, links to the selected data sets and is supported by integration with a BioUML platform [3] that provides web access and wide spectrum of tools for comprehensive analysis.
Database access
RiboSeqDB is available at http://micro.biouml.org/bioumlweb/ via the BioUMLweb platform. 
Data parameters
All data samples indexed by RiboSeqDB are characterized with a range of parameters (info fields) that were filled in during input to the database [ Figure 4 ]. Name -this field is filled in automatically by the database, this is ID of a sample. All other fields are filled in manually.
Title -a title of an experiment that comprises the inputed data sample.
Description -description of either the data sample or the experiment; a short commentary is also possible.
Species -species of the organism from the experiment. The species is selected from the dropdown menu, and before the input all necessary species have to be added to the data collection 'Species' ([ Figure 3] , in red rectangle).
Cell source -a cell line or any other kind of cells that can be selected from the drop-down menu.
Cell source has to be preinputed in the data collection 'Cells' ([ Figure 3 ], in red rectangle).
Translation inhibition -an inhibitor of translation that was used in the experiment.
Minimal fragment size -minimal size of the sequenced fragments.
Maximal fragment size -maximal size of the sequenced fragments.
Digestion -an enzyme used for digestion of mRNA.
3' sequence adapter -adapter at the 3' termini of reads used for preparation to sequencing procedure. Sequencing platform -a commercial or self-made sequencing platform that was used to get reads selected from the drop-down menu and, hence, that has to be preinputed in the data collection 'Sequencing platforms' ([ Figure 3] , in red rectangle).
Conditions
Sequence data -info on data sample splitted into Format (well-known international formats FASTA, FASTQ, SRA and ELAND are available from the drop-down menu) and URL (a direct link to the file of raw experimental data).
SRA project id -an identifier of the data sample's project in the SRA database (if available), usually of kind of SRPXXXXXX.
SRA experiment id -an identifier of the data sample in the SRA database (if available), usually kind of SRXAAAAAA.
GEO series id -an identifier of the data series in the GEO database (if available), usually kind of GSEXXXXX.
GEO sample id -an identifier of the data sample in the GEO database (if available), usually kind of GSMXXXXXX.
PubMed Identifiers -an identifier of the article indexed in PubMed that describes the experiment comprising inputed data sample.
Either missing fields or fields demanding more precise definitions are postponed and can be filled in later. The list of the inputed data can be obtained by double-click on the folder 'Experiments' from the 'Data' folder of the RiboSeqDB database.
[ Figure 5 ] demonstrates the opened 'Experiments' table with the inputed data. As the input, sequenced data format SRA is acceptable (SRRs from the SRA database). 3' adapters are trimmed in the reads basing on the sequencing platform and experiment design information. Reads less than 9 bp are filtered, as well as the reads corresponding to known rRNAs, tRNAs and snRNAs using well-known sequence aligner Bowtie2. Track statistics is gathered at the every step of filtering procedure. Filtered/preprocessed FASTQ then is concatenated and transferred to Tophat2 -"a fast splice junction mapper for RNA-Seq reads. It aligns RNA-Seq reads to mammalian-sized genomes using the ultra highthroughput short read aligner Bowtie, and then analyzes the mapping results to identify splice junctions between exons." [4] . Reads that cannot be mapped unambiguously are removed from the process. Unique alignments are transferred to Read counter supported with annotation data from the Ensembl database, then number of reads corresponding to genes is calculated and the preprocessing procedure, thus, is finished. The final step is calculation of reads mapped to transcripts (http://micro.biouml.org/bioumlweb/#de=analyses/Methods/BSA/Count%20reads%20in%20transcripts; then select 'Demo'). This number of the mapped reads is taken into account for estimation of translation level of mRNAs.
RiboSeq data processing
Application of workflows allows to perform processing automatically of big volumes of experimental data and by the same manner, applying corrections if it is necessary. This is important by several causes:
-same order of processing leads to non-biased results induced by application of different methods to raw data; -speed up of the process and easily reproduction of the whole chain of manipulations with data due to the logging in journal; -more convenient conditions for debugging of the data processing pipeline; -easy modification of the list of the allied methods and processing parameters (thresholds, etc).
RiboSeqDB statistics
Currently, RiboSeqDB contains data corresponding to the following cell lines:
Experiments -290 samples in 21 datasets in total. 
Cell lines and cell types

Future prospects
Current state of RiboSeqDB is not final. The next stage of work will be bridging all the gaps using literature data and sequencing protocols. RiboSeqDB is the repository, both, for storage and fast application of data freely available from the public sources and their integration with the results of analysis performed in the frames of our research projects. This database is a part of the BioUML scientific platform that provides extended functionality for users covering wide spectrum of possible tasks starting from the formal description of the research object and modeling and ending with processing of the data obtained with modern high-throughput '-omic' methods. In complex with BioUML, RiboSeqDB will provide users with reliable informatics support, fast and convenient navigation, data search, supply with a big enough set of tools for analysis and become a safe harbour for data storage and exchange. Next year it is planning to implement a workflow for processing of raw ribosome footprint data that will allow a user to reach new horizons and get new advantages in analysis of genome information realization in cells meanwhile approaching to 'Virtual Human' implementation.
